Utilization of bone densitometry and administration of bisphosphonates to prevent osteoporosis in patients with nonmetastatic prostate cancer receiving anti-androgen therapy

被引：0
|
作者：
Khan, Muhammad Atif
Holt, Abby E.
Gujja, Swetha
Govindarajan, Rangaswamy
机构：
[1] Univ Arkansas Med Sci Hosp, Little Rock, AR 72205 USA
[2] Arkansas Dept Hlth, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6099
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Utilization of bone densitometry for prediction and administration of bisphosphonates to prevent osteoporosis in patients with prostate cancer without bone metastases receiving antiandrogen therapy
    Holt, Abby
    Khan, Muhammad A.
    Gujja, Swetha
    Govindarajan, Rangaswmy
    CANCER MANAGEMENT AND RESEARCH, 2015, 7 : 13 - 18
  • [2] Bisphosphonates to prevent osteoporosis in men receiving androgen deprivation therapy for prostate cancer
    Smith, MR
    DRUGS & AGING, 2003, 20 (03) : 175 - 183
  • [3] Bisphosphonates to Prevent Osteoporosis in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Matthew R. Smith
    Drugs & Aging, 2003, 20 : 175 - 183
  • [4] Prevalence of osteoporosis in patients with prostate cancer on anti-androgen therapy
    Senan Sanz, M. R.
    Haro Iniesta, L.
    Riel Cabrera, R.
    Olive Ferre, F. X.
    Biel Arrufat, A.
    Matinero Romero, E.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 151S - 151S
  • [5] Bisphosphonates for Osteoporosis in Nonmetastatic Prostate Cancer Patients Receiving Androgen-deprivation Therapy: A Systematic Review and Meta-analysis
    Ding, Hui
    Yang, Li
    Du, Wan
    Teng, Yang
    Fu, Sheng-Jun
    Tao, Yan
    Lu, Jian-Zhong
    Wang, Zhi-Ping
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (05) : 3337 - 3343
  • [6] Bone health in prostate cancer patients receiving androgen-deprivation therapy: the role of bisphosphonates
    Polascik, T. J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2008, 11 (01) : 13 - 19
  • [7] Bone health in prostate cancer patients receiving androgen-deprivation therapy: the role of bisphosphonates
    T J Polascik
    Prostate Cancer and Prostatic Diseases, 2008, 11 : 13 - 19
  • [8] Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer
    Smith, MR
    Eastham, J
    Gleason, DM
    Shasha, D
    Tchekmedyian, S
    Zinner, N
    JOURNAL OF UROLOGY, 2003, 169 (06): : 2008 - 2012
  • [9] Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
    Zhang, Haozhe
    Zhou, Yi
    Xing, Zengzhen
    Sah, Rajiv Kumar
    Hu, Junqi
    Hu, Hailiang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [10] Re: Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer
    Pitts, WR
    JOURNAL OF UROLOGY, 2003, 170 (06): : 2392 - 2393
12345